期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

耐药结核病的药物选择 被引量：3

Drug selection of drug-resistant tuberculosis
下载PDF
导出
摘要 耐药结核病是结核病控制的难题,对其治疗依赖于现有药物的种类合理选择和剂量精心调整,部分患者需要外科辅助治疗,在未来免疫治疗可能起到重要作用。本文对耐药结核病的药物选择进行阐述。 Drugresistant tuberculosis remains a difficult problem that threatens progress made in tuberculosis control. Management strategies for drugresistant tuberculosis rely on harnessing existing drugs in the best combinations and dosing schedules, together with adjunctive surgery in carefully selected cases. Immunotherapy may also play an important role in the future. This arti-cle focuses on drug selection of drug-resistant tuberculosis.
作者 胡越凯 卢洪洲
机构地区 复旦大学附属华山医院感染科 上海市(复旦大学附属)公共卫生临床中心感染科
出处 《传染病信息》 2014年第3期139-142,共4页 Infectious Disease Information
基金 国家"十二五"科技重大专项(2012ZX10001-003)
关键词 结核 药物耐受性 抗结核药 治疗学 tuberculosis drug tolerance antitubercular agents therapeutics
分类号 R52 [医药卫生—内科学]
  • 相关文献

参考文献39

  • 1World Health Organization. Policy guidance on drug susceptibility testing(DST)of second-line antituberculosis drugs[EB/OL].http://whqlibdoc.who.int/hq/2008/WHO_HTM_TB_2008.392_eng.pdf ua=1,2014.
  • 2Velayati AA,Farnia P,Masjedi MR. The totally drug resistant tu-berculosis(TDR-TB)[J].Int J Clin Exp Med,2013,(04):307-309.
  • 3Kim DH,Kim HJ,Park S-K. Treatment outcomes and sur-vival based on drug resistance patterns in multidrug-resistant tu-berculosis[J].American Journal of Respiratory and Critical Care Medicine,2010,(01):113-119.
  • 4World Health Organization. Treatment of tuberculosis guidelines. Fourth edition[EB/OL].http://whqlibdoc.who.int/publications/2010/9789241547833_eng.pdf ua=1,2014.
  • 5Katiyar SK,Bihari S,Prakash S. A randomised controlled trial of high-dose isoniazid adjuvant therapy for multidrug-resis-tant tuberculosis[J].International Journal of Tuberculosis and Lung Disease,2008,(02):139-145.
  • 6Peloquin CA. Therapeutic drug monitoring in the treatment of tu-berculosis[J].DRUGS,2002,(15):2169-2183.
  • 7World Health Organization. Guidelines for the programmatic man-agement of drug-resistant tuberculosis[EB/OL].http://whqlibdoc.who.int/publications/2008/9789241547581_eng.pdf ua=1,2014.
  • 8Zhang Y,Chang KC,Leung CC. ZS-MDR-TB'versus'ZR-MDR-TB':improving treatment of MDR-TB by identifying pyra-zinamide susceptibility[J].Emerg Microbes Infect,2012.e5-e4.
  • 9Jacobson KR,Tierney DB,Jeon CY. Treatment outcomes among patients with extensively drug-resistant tuberculosis:sys-tematic review and meta-analysis[J].Clinical Infectious Diseases,2010,(01):6-14.
  • 10Poissy J,Aubry A,Fernandez C. Should moxifloxacin be used for the treatment of extensively drug-resistant tuberculosis An answer from a murine model[J].Antimicrobial Agents and Chemotherapy,2010,(11):4765-4771.

二级参考文献98

  • 1WHO.狂犬病[EB/OL].[2010-12-01].httpd/www.who.int/mediacentre/factsheets/fs099/zh/index.html.
  • 2卫生部国际合作司国际组织处,中国疾病预防控制中心公共卫生监测与信息服务中心联合编译[R].世界卫生组织简报(2012),2012,第1-24期(总第499-522期).
  • 3WHO.苏丹黄热病[EB/OL].[2012-12-10].http://www.who.int/csr/don/2012_12_06/zh/index.html.
  • 4WHO.尼日利亚的拉沙热[EB/OL].[2012-12-15].http://www.who.int/csr/don/2012_04_04/zh/.
  • 5WHO.脑膜炎球菌病:非洲脑膜炎地带情况[EB/OL].[2012-12-15].http://www.who.int/csr/don/2012_05_24/zh/.
  • 6WHO.世界卫生组织:需要采取紧急行动预防无法治疗的淋病传播[EB/OL].[2012-12-151.http://www.who.int/mediacentre/news/notes/2012/gonorrhoea_20120606/zh/index.html.
  • 7WHO.柬埔寨的未知疾病-最新简报[EB/OL].[2012-12-15].http://www.who.int/csr/don/2012_07_09/zh/.
  • 8WHO.71型肠道病毒在柬埔寨引起的手足口病严重并发症-联合调查结论[EB/OL].[2012-12-10].http://www.who.inl/csr/don/2012_07_13/zh/.
  • 9WHO.2012年世界肝炎日[EB/OL].[2012-12-12].http://www.who.int/csr/disease/hepatitis/wodd_hepatitis_day/zh/index.html.
  • 10WHO.乌干达埃博拉-最新简报[EB/OL].[2012-12-15].http://www.who.int/csr/don/2012_09_03/zh/index.html.

共引文献42

同被引文献32

引证文献3

二级引证文献23

传染病信息
2014年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部